We described a significant increase of XA in untreated MS-patients: KAT2 is also expressed in red blood cells (RBCs) and, its activity is higher in RBCs of MS patients, that could be a possible explanation of the increase found (31, 32). Here, AADAT is linked to myeloid sarcoma.